Event Overview

Event Overview

The US Pharma and Biotech Summit is the essential virtual event for business leaders, innovators and policymakers to explore how the sector can adapt to meet a new set of challenges and opportunities for the post-pandemic era. Following the success of our digital event in 2020, we are continuing to use an online platform this year. On the 5 May 2021, there follow two days of unique themes, sessions and speakers for our senior-level audience to engage with.

Hear from the industry’s leading decision-makers as they plan for growth after COVID-19 and question where the legacy of collaboration can continue

Digitally connect with over 300 industry representatives through unique online networking opportunities

Two days of FT-curated content designed to help shape the future of the sector

Built on a 30-year track record of trusted and successful FT healthcare events

Meet and do business with senior executives from all functions of the pharmaceutical and biotechnology supply chain

VP, Strategic Data and Digital, US Oncology, Novartis
“The US Pharma and Biotech Summit was engaging and educational. The sessions highlighted the complexities that we have in the US healthcare system and the various viewpoints that we should all consider.”

2020 speakers included:

Stephen M. Hahn, Commissioner, U.S. Food & Drug Administration (FDA)

Jessica Mega, Chief Medical & Scientific Officer, Verily

Stéphane Bancel, CEO, Moderna Therapeutics

Susan Shiff, SVP - Centre for Observational and Real World Evidence, MSD

Robert Bradway, Chairman and CEO, Amgen

Terry Wilcox, Executive Director, Patients Rising

300+ attendees
30+ speakers
2 days of FT-curated healthcare content